Identify and quantify biomarkers, drug targets and impurities in all your biological samples.
Identify and quantify biomarkers, drug targets and impurities in all your biological samples.
Tailored methods to detect and quantify specific proteins or complex proteomes with proprietary technology.
Sensitive and reliable proteomic analysis to explore disease mechanisms and therapeutic targets.
Comprehensive profiling to meet regulatory expectations for biologics and gene or cell therapy products.
Designed to match the unique needs of your research or development program.
At ANAQUANT, we provide advanced mass spectrometry–based proteomics services designed to accelerate drug development and bioproduction projects. Our expertise covers the identification, characterization, and quantification of proteins with a high level of accuracy and reproducibility.
By combining our proprietary technologies with cutting-edge LC-MS/MS instrumentation, we support biopharma and biotech companies in solving critical analytical challenges, from biomarker validation to biotherapeutic characterization.
> Generating validated proteomics data for regulatory dossiers.
> Monitoring impurities, residual proteins, and process-related contaminants.
> Supporting translational studies and clinical research through targeted proteomics.